首页|MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport

MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport

扫码查看
Objective: To determine whether miR-125b regulates cholesterol efflux in vivo and in vitro through the regulation of scavenger receptor type B1 (SR-B1). Approach and results: We demonstrated that miR-125b is up-regulated in the human aortas of patients with CAD and is located in macrophages and vascular smooth muscle cells (VSMCs). We identified SCARB1 as a direct target of miR-125b by repressing the activity of the SCARB1 3'-untranslated region reporter construct. Moreover, the overexpression of miR-125b in both human and mouse macrophages as well as VSMCs was found to downregulated the expression of the SCARB1 and the SR-B1 protein levels, thereby impairing α-HDL-mediated macrophage cholesterol efflux in vitro. The in vivo reverse cholesterol transport (RCT) rate from non-cholesterol-loaded macrophages transfected with miR-125b to feces was also found to be decreased when compared with that of control mimic-transfected macrophages. Conclusions: Together, these results provide evidence that miR-125b downregulates SCARB1 and SR-B1 in both human and mouse macrophages as well as VSMCs, thereby impairing macrophage cholesterol efflux in vitro and the whole macrophage-specific RCT pathway in vivo.

Cholesterol effluxReverse cholesterol transportScavenger receptor class B type 1 (SRB1)MicroRNAMiR-125bMacrophageVascular smooth muscle cellCoronary artery disease

Miguel Hueso、Raquel Gririan、Adrian Mallen、Estanislao Navarro、Elvira Purqueras、Montse Goma、Fabrizio Sbraga、Giovanna Revilla、David Santos、Marina Canyelles、Josep Julve、Joan Carles Escola-Gil、Noemi Rotllan、Arnau Blasco-Lucas

展开 >

Department of Nephrology, Hospital Universitari Bellvitge and Bellvitge Research Institute (IDIBELL

2022

Biomedicine & pharmacotherapy

Biomedicine & pharmacotherapy

SCI
ISSN:0753-3322
年,卷(期):2022.146